Clinical Trials List
Protocol NumberCKFA115A12101
Active
2022-11-01 - 2026-01-30
Phase I
Not yet recruiting1
ICD-10C11.0
Malignant neoplasm of superior wall of nasopharynx
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9147.0
Malignant neoplasm of superior wall of nasopharynx
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- CHAO-CHI HO CHAO-CHI HO 無
- JIN-YUAN SHIH 無
- James Chih-Hsin Yang 無
- 蔡子修 無
- Jih-Hsiang Lee 無
- Chong-Jen Yu 無
- 徐偉勛 無
- 楊景堯 無
- Yu-Chieh Tsai 無
- YEN-TING LIN 無
- 吳尚俊 無
- 許嘉林 無
- 廖唯昱 無
- FU-JEN HSUEH 無
- Ying-Chun Shen 無
- JHE-CYUAN GUO 無
- 廖斌志 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
180 participants
